Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-02-06

FDA Approved: ALENDRONATE SODIUM — Original Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved the original ANDA for Alendronate Sodium (generic) from Amneal Pharmaceuticals of New York LLC, expanding access for treatment of osteoporosis and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

ORIG AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)